Fig. 3From: Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidednessResults of univariable analysis for progression-free, overall survival and objective response rate (ORR). Location: “right” = right colon, “left” = left colon and rectum. ALC = absolute lymphocyte countBack to article page